カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のバルサルタン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Valsartan Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19684）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19684
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のバルサルタン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

バルサルタン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のバルサルタンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

バルサルタン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・40mg錠、80mg錠、160mg錠、320mg錠

用途別セグメントは次のように区分されます。
・高血圧症、心不全、心臓発作

世界のバルサルタン市場の主要な市場プレーヤーは以下のとおりです。
・Novartis、Sun Pharmaceutical、Teva、Mylan、Alembic Pharmaceuticals、Lupin、Aurobindo Pharma、Macleods Pharmaceuticals、HETERO、Torrent Pharmaceuticals、Huaren Pharmaceutical、Jubilant Pharma、Amneal Pharmaceuticals、Zhejiang Huahai Pharmaceutical、Square Pharmaceuticals、Unichem Laboratories、LG Life Sciences

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、バルサルタン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバルサルタンメーカーの企業概要、2019年～2022年までのバルサルタンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバルサルタンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別バルサルタンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのバルサルタンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバルサルタン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびバルサルタンの産業チェーンを掲載しています。
・第13、14、15章では、バルサルタンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- バルサルタンの概要
- 種類別分析（2017年vs2021年vs2028年）：40mg錠、80mg錠、160mg錠、320mg錠
- 用途別分析（2017年vs2021年vs2028年）：高血圧症、心不全、心臓発作
- 世界のバルサルタン市場規模・予測
- 世界のバルサルタン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis、Sun Pharmaceutical、Teva、Mylan、Alembic Pharmaceuticals、Lupin、Aurobindo Pharma、Macleods Pharmaceuticals、HETERO、Torrent Pharmaceuticals、Huaren Pharmaceutical、Jubilant Pharma、Amneal Pharmaceuticals、Zhejiang Huahai Pharmaceutical、Square Pharmaceuticals、Unichem Laboratories、LG Life Sciences
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：40mg錠、80mg錠、160mg錠、320mg錠
・用途別分析2017年-2028年：高血圧症、心不全、心臓発作
・バルサルタンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・バルサルタンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・バルサルタンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・バルサルタンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・バルサルタンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Valsartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Valsartan market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hypertension accounting for % of the Valsartan global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 40 mg Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Valsartan include Novartis, Sun Pharmaceutical, Teva, Mylan, and Alembic Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Valsartan market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Market segment by Application can be divided into
Hypertension
Heart Failure
Heart Attack
The key market players for global Valsartan market are listed below:
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Valsartan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Valsartan, with price, sales, revenue and global market share of Valsartan from 2019 to 2022.
Chapter 3, the Valsartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valsartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Valsartan market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Valsartan.
Chapter 13, 14, and 15, to describe Valsartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Valsartan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Valsartan Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Valsartan Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Global Valsartan Market Size & Forecast
1.4.1 Global Valsartan Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Valsartan Sales in Volume (2017-2028)
1.4.3 Global Valsartan Price (2017-2028)
1.5 Global Valsartan Production Capacity Analysis
1.5.1 Global Valsartan Total Production Capacity (2017-2028)
1.5.2 Global Valsartan Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Valsartan Market Drivers
1.6.2 Valsartan Market Restraints
1.6.3 Valsartan Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Valsartan Product and Services
2.1.4 Novartis Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business
2.2.3 Sun Pharmaceutical Valsartan Product and Services
2.2.4 Sun Pharmaceutical Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Valsartan Product and Services
2.3.4 Teva Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Valsartan Product and Services
2.4.4 Mylan Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Alembic Pharmaceuticals
2.5.1 Alembic Pharmaceuticals Details
2.5.2 Alembic Pharmaceuticals Major Business
2.5.3 Alembic Pharmaceuticals Valsartan Product and Services
2.5.4 Alembic Pharmaceuticals Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Valsartan Product and Services
2.6.4 Lupin Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Valsartan Product and Services
2.7.4 Aurobindo Pharma Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Macleods Pharmaceuticals
2.8.1 Macleods Pharmaceuticals Details
2.8.2 Macleods Pharmaceuticals Major Business
2.8.3 Macleods Pharmaceuticals Valsartan Product and Services
2.8.4 Macleods Pharmaceuticals Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 HETERO
2.9.1 HETERO Details
2.9.2 HETERO Major Business
2.9.3 HETERO Valsartan Product and Services
2.9.4 HETERO Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Valsartan Product and Services
2.10.4 Torrent Pharmaceuticals Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Huaren Pharmaceutical
2.11.1 Huaren Pharmaceutical Details
2.11.2 Huaren Pharmaceutical Major Business
2.11.3 Huaren Pharmaceutical Valsartan Product and Services
2.11.4 Huaren Pharmaceutical Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jubilant Pharma
2.12.1 Jubilant Pharma Details
2.12.2 Jubilant Pharma Major Business
2.12.3 Jubilant Pharma Valsartan Product and Services
2.12.4 Jubilant Pharma Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Amneal Pharmaceuticals
2.13.1 Amneal Pharmaceuticals Details
2.13.2 Amneal Pharmaceuticals Major Business
2.13.3 Amneal Pharmaceuticals Valsartan Product and Services
2.13.4 Amneal Pharmaceuticals Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Zhejiang Huahai Pharmaceutical
2.14.1 Zhejiang Huahai Pharmaceutical Details
2.14.2 Zhejiang Huahai Pharmaceutical Major Business
2.14.3 Zhejiang Huahai Pharmaceutical Valsartan Product and Services
2.14.4 Zhejiang Huahai Pharmaceutical Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Square Pharmaceuticals
2.15.1 Square Pharmaceuticals Details
2.15.2 Square Pharmaceuticals Major Business
2.15.3 Square Pharmaceuticals Valsartan Product and Services
2.15.4 Square Pharmaceuticals Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Unichem Laboratories
2.16.1 Unichem Laboratories Details
2.16.2 Unichem Laboratories Major Business
2.16.3 Unichem Laboratories Valsartan Product and Services
2.16.4 Unichem Laboratories Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 LG Life Sciences
2.17.1 LG Life Sciences Details
2.17.2 LG Life Sciences Major Business
2.17.3 LG Life Sciences Valsartan Product and Services
2.17.4 LG Life Sciences Valsartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Valsartan Breakdown Data by Manufacturer
3.1 Global Valsartan Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Valsartan Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Valsartan
3.4 Market Concentration Rate
3.4.1 Top 3 Valsartan Manufacturer Market Share in 2021
3.4.2 Top 6 Valsartan Manufacturer Market Share in 2021
3.5 Global Valsartan Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Valsartan Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Valsartan Market Size by Region
4.1.1 Global Valsartan Sales in Volume by Region (2017-2028)
4.1.2 Global Valsartan Revenue by Region (2017-2028)
4.2 North America Valsartan Revenue (2017-2028)
4.3 Europe Valsartan Revenue (2017-2028)
4.4 Asia-Pacific Valsartan Revenue (2017-2028)
4.5 South America Valsartan Revenue (2017-2028)
4.6 Middle East and Africa Valsartan Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Valsartan Sales in Volume by Type (2017-2028)
5.2 Global Valsartan Revenue by Type (2017-2028)
5.3 Global Valsartan Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Valsartan Sales in Volume by Application (2017-2028)
6.2 Global Valsartan Revenue by Application (2017-2028)
6.3 Global Valsartan Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Valsartan Sales by Type (2017-2028)
7.2 North America Valsartan Sales by Application (2017-2028)
7.3 North America Valsartan Market Size by Country
7.3.1 North America Valsartan Sales in Volume by Country (2017-2028)
7.3.2 North America Valsartan Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Valsartan Sales by Type (2017-2028)
8.2 Europe Valsartan Sales by Application (2017-2028)
8.3 Europe Valsartan Market Size by Country
8.3.1 Europe Valsartan Sales in Volume by Country (2017-2028)
8.3.2 Europe Valsartan Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Valsartan Sales by Type (2017-2028)
9.2 Asia-Pacific Valsartan Sales by Application (2017-2028)
9.3 Asia-Pacific Valsartan Market Size by Region
9.3.1 Asia-Pacific Valsartan Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Valsartan Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Valsartan Sales by Type (2017-2028)
10.2 South America Valsartan Sales by Application (2017-2028)
10.3 South America Valsartan Market Size by Country
10.3.1 South America Valsartan Sales in Volume by Country (2017-2028)
10.3.2 South America Valsartan Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Valsartan Sales by Type (2017-2028)
11.2 Middle East & Africa Valsartan Sales by Application (2017-2028)
11.3 Middle East & Africa Valsartan Market Size by Country
11.3.1 Middle East & Africa Valsartan Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Valsartan Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Valsartan and Key Manufacturers
12.2 Manufacturing Costs Percentage of Valsartan
12.3 Valsartan Production Process
12.4 Valsartan Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Valsartan Typical Distributors
13.3 Valsartan Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Valsartan Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Valsartan Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Valsartan Product and Services
Table 6. Novartis Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Sun Pharmaceutical Major Business
Table 9. Sun Pharmaceutical Valsartan Product and Services
Table 10. Sun Pharmaceutical Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Valsartan Product and Services
Table 14. Teva Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Valsartan Product and Services
Table 18. Mylan Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Alembic Pharmaceuticals Major Business
Table 21. Alembic Pharmaceuticals Valsartan Product and Services
Table 22. Alembic Pharmaceuticals Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Valsartan Product and Services
Table 26. Lupin Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Aurobindo Pharma Major Business
Table 29. Aurobindo Pharma Valsartan Product and Services
Table 30. Aurobindo Pharma Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Macleods Pharmaceuticals Major Business
Table 33. Macleods Pharmaceuticals Valsartan Product and Services
Table 34. Macleods Pharmaceuticals Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. HETERO Basic Information, Manufacturing Base and Competitors
Table 36. HETERO Major Business
Table 37. HETERO Valsartan Product and Services
Table 38. HETERO Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Torrent Pharmaceuticals Major Business
Table 41. Torrent Pharmaceuticals Valsartan Product and Services
Table 42. Torrent Pharmaceuticals Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Huaren Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Huaren Pharmaceutical Major Business
Table 45. Huaren Pharmaceutical Valsartan Product and Services
Table 46. Huaren Pharmaceutical Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Jubilant Pharma Major Business
Table 49. Jubilant Pharma Valsartan Product and Services
Table 50. Jubilant Pharma Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Amneal Pharmaceuticals Major Business
Table 53. Amneal Pharmaceuticals Valsartan Product and Services
Table 54. Amneal Pharmaceuticals Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Zhejiang Huahai Pharmaceutical Major Business
Table 57. Zhejiang Huahai Pharmaceutical Valsartan Product and Services
Table 58. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Square Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Square Pharmaceuticals Major Business
Table 61. Square Pharmaceuticals Valsartan Product and Services
Table 62. Square Pharmaceuticals Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Unichem Laboratories Major Business
Table 65. Unichem Laboratories Valsartan Product and Services
Table 66. Unichem Laboratories Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 68. LG Life Sciences Major Business
Table 69. LG Life Sciences Valsartan Product and Services
Table 70. LG Life Sciences Valsartan Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Valsartan Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Valsartan Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Valsartan, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Valsartan Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Valsartan Production Site of Key Manufacturer
Table 76. Valsartan New Entrant and Capacity Expansion Plans
Table 77. Valsartan Mergers & Acquisitions in the Past Five Years
Table 78. Global Valsartan Sales by Region (2017-2022) & (K Units)
Table 79. Global Valsartan Sales by Region (2023-2028) & (K Units)
Table 80. Global Valsartan Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Valsartan Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Valsartan Sales by Type (2017-2022) & (K Units)
Table 83. Global Valsartan Sales by Type (2023-2028) & (K Units)
Table 84. Global Valsartan Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Valsartan Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Valsartan Price by Type (2017-2022) & (US$/Unit)
Table 87. Global Valsartan Price by Type (2023-2028) & (US$/Unit)
Table 88. Global Valsartan Sales by Application (2017-2022) & (K Units)
Table 89. Global Valsartan Sales by Application (2023-2028) & (K Units)
Table 90. Global Valsartan Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Valsartan Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Valsartan Price by Application (2017-2022) & (US$/Unit)
Table 93. Global Valsartan Price by Application (2023-2028) & (US$/Unit)
Table 94. North America Valsartan Sales by Country (2017-2022) & (K Units)
Table 95. North America Valsartan Sales by Country (2023-2028) & (K Units)
Table 96. North America Valsartan Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Valsartan Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Valsartan Sales by Type (2017-2022) & (K Units)
Table 99. North America Valsartan Sales by Type (2023-2028) & (K Units)
Table 100. North America Valsartan Sales by Application (2017-2022) & (K Units)
Table 101. North America Valsartan Sales by Application (2023-2028) & (K Units)
Table 102. Europe Valsartan Sales by Country (2017-2022) & (K Units)
Table 103. Europe Valsartan Sales by Country (2023-2028) & (K Units)
Table 104. Europe Valsartan Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Valsartan Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Valsartan Sales by Type (2017-2022) & (K Units)
Table 107. Europe Valsartan Sales by Type (2023-2028) & (K Units)
Table 108. Europe Valsartan Sales by Application (2017-2022) & (K Units)
Table 109. Europe Valsartan Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Valsartan Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Valsartan Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Valsartan Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Valsartan Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Valsartan Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Valsartan Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Valsartan Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Valsartan Sales by Application (2023-2028) & (K Units)
Table 118. South America Valsartan Sales by Country (2017-2022) & (K Units)
Table 119. South America Valsartan Sales by Country (2023-2028) & (K Units)
Table 120. South America Valsartan Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Valsartan Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Valsartan Sales by Type (2017-2022) & (K Units)
Table 123. South America Valsartan Sales by Type (2023-2028) & (K Units)
Table 124. South America Valsartan Sales by Application (2017-2022) & (K Units)
Table 125. South America Valsartan Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Valsartan Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Valsartan Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Valsartan Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Valsartan Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Valsartan Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Valsartan Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Valsartan Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Valsartan Sales by Application (2023-2028) & (K Units)
Table 134. Valsartan Raw Material
Table 135. Key Manufacturers of Valsartan Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Valsartan Typical Distributors
Table 139. Valsartan Typical Customers
List of Figures
Figure 1. Valsartan Picture
Figure 2. Global Valsartan Revenue Market Share by Type in 2021
Figure 3. 40 mg Tablets
Figure 4. 80 mg Tablets
Figure 5. 160 mg Tablets
Figure 6. 320 mg Tablets
Figure 7. Global Valsartan Revenue Market Share by Application in 2021
Figure 8. Hypertension
Figure 9. Heart Failure
Figure 10. Heart Attack
Figure 11. Global Valsartan Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Valsartan Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Valsartan Sales (2017-2028) & (K Units)
Figure 14. Global Valsartan Price (2017-2028) & (US$/Unit)
Figure 15. Global Valsartan Production Capacity (2017-2028) & (K Units)
Figure 16. Global Valsartan Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Valsartan Market Drivers
Figure 18. Valsartan Market Restraints
Figure 19. Valsartan Market Trends
Figure 20. Global Valsartan Sales Market Share by Manufacturer in 2021
Figure 21. Global Valsartan Revenue Market Share by Manufacturer in 2021
Figure 22. Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Valsartan Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Valsartan Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Valsartan Sales Market Share by Region (2017-2028)
Figure 26. Global Valsartan Revenue Market Share by Region (2017-2028)
Figure 27. North America Valsartan Revenue (2017-2028) & (USD Million)
Figure 28. Europe Valsartan Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Valsartan Revenue (2017-2028) & (USD Million)
Figure 30. South America Valsartan Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Valsartan Revenue (2017-2028) & (USD Million)
Figure 32. Global Valsartan Sales Market Share by Type (2017-2028)
Figure 33. Global Valsartan Revenue Market Share by Type (2017-2028)
Figure 34. Global Valsartan Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Valsartan Sales Market Share by Application (2017-2028)
Figure 36. Global Valsartan Revenue Market Share by Application (2017-2028)
Figure 37. Global Valsartan Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Valsartan Sales Market Share by Type (2017-2028)
Figure 39. North America Valsartan Sales Market Share by Application (2017-2028)
Figure 40. North America Valsartan Sales Market Share by Country (2017-2028)
Figure 41. North America Valsartan Revenue Market Share by Country (2017-2028)
Figure 42. United States Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Valsartan Sales Market Share by Type (2017-2028)
Figure 46. Europe Valsartan Sales Market Share by Application (2017-2028)
Figure 47. Europe Valsartan Sales Market Share by Country (2017-2028)
Figure 48. Europe Valsartan Revenue Market Share by Country (2017-2028)
Figure 49. Germany Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Valsartan Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Valsartan Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Valsartan Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Valsartan Revenue Market Share by Region (2017-2028)
Figure 58. China Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Valsartan Sales Market Share by Type (2017-2028)
Figure 65. South America Valsartan Sales Market Share by Application (2017-2028)
Figure 66. South America Valsartan Sales Market Share by Country (2017-2028)
Figure 67. South America Valsartan Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Valsartan Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Valsartan Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Valsartan Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Valsartan Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Valsartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Valsartan in 2021
Figure 79. Manufacturing Process Analysis of Valsartan
Figure 80. Valsartan Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • バルサルタンAPIのグローバル市場展望 2023年-2029年：純度≧99.5%、純度≧99.9%
  • 世界の医薬品用容器閉鎖装置（CCS）市場2022年：市場規模予測（～2028年）
  • 世界のワクチン及び医薬品用ガラス瓶＆バイアル市場2022年：市場規模予測（～2028年）
  • 医薬品及び賦形剤のグローバル市場展望 2023年-2029年：中性脂肪、マンニトール、ソルビトール、ショ糖、ブドウ糖、でんぷん、その他
  • 医薬品用コールドチェーン物流の世界市場 2022年-2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19684 )"世界のバルサルタン市場2022年：市場規模予測（～2028年）" (英文：Global Valsartan Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。